We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PLRZ market cap is 4.2M. The company's latest EPS is USD -0.1484 and P/E is -7.28.
| Quarter End | ||||
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | ||||
| Operating Income | ||||
| Net Income |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -72k | -703k | -895k | -635k |
| Net Income | -73k | -711k | -779k | -600k |
| Quarter End | ||||
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | ||||
| Total Liabilities | ||||
| Total Equity |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24k | 687k | 546k | 559k |
| Total Liabilities | 8k | 690k | 1.2M | 502k |
| Total Equity | -232k | -251k | -900k | -191k |
| Market Cap | 4.2M |
| Price to Earnings Ratio | -7.28 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.08k |
| Price to Book Ratio | 76.61 |
| Dividend Yield | - |
| Shares Outstanding | 4.04M |
| Average Volume (1 week) | 61.42k |
| Average Volume (1 Month) | 143.16k |
| 52 Week Change | -36.60% |
| 52 Week High | 4.80 |
| 52 Week Low | 0.77 |
| Spread (Intraday) | 0.13 (11.21%) |
| Company Name | Polyrizon Ltd |
| Address |
5 ha-tidhar street ra'anana, center 4366507 |
| Website | https://www.polyrizon-biotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
